Who should be screened for osteoporosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Screening for osteoporosis is recommended for women aged 65 and older and men aged 70 and older, as well as for younger individuals with risk factors such as low body weight, family history of osteoporosis, smoking, excessive alcohol consumption, long-term steroid use, rheumatoid arthritis, or early menopause before age 45. According to the most recent and highest quality study, 1, osteoporosis constitutes a significant public health risk, and dual-energy X-ray absorptiometry (DXA) is the primary imaging modality used to screen for osteoporosis.

Key Points to Consider

  • The USPSTF recommends routine screening for osteoporosis in women 65 years of age and older, and in women 60 to 64 years of age who are at increased risk for osteoporotic fractures 1.
  • Younger individuals with risk factors should also be screened, as they may benefit from early detection and intervention 1.
  • DXA is the primary diagnostic modality for screening, and it measures bone mineral density at the hip and spine.
  • Other technologies, such as vertebral fracture assessment and trabecular bone score, may further predict fracture risk in certain situations 1.
  • Quantitative CT is useful in patients with advanced degenerative changes in the spine 1.

Recommendations for Screening

  • Women aged 65 and older should be screened routinely for osteoporosis.
  • Men aged 70 and older should be screened routinely for osteoporosis.
  • Younger individuals with risk factors, such as low body weight, family history of osteoporosis, smoking, excessive alcohol consumption, long-term steroid use, rheumatoid arthritis, or early menopause before age 45, should be screened.
  • Screening should typically involve a DXA scan, which measures bone mineral density at the hip and spine.
  • Follow-up DXA scans are typically recommended every 1-2 years to monitor treatment effectiveness.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.